InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by McCain Tracey L, Directeur Juridique. Insider active across 3 companies, notably Blueprint Medicines Corp. In total, 15 reports have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €1.1m. History available since 23 September 2021. The latest transaction was disclosed on 5 March 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to McCain Tracey L
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
21,353 sharesCommon StockSEC:0001104659-25-069381:0
3,173 sharesClass A Ordinary ShareSEC:0001415889-25-015792:0
5,262 shares@ US$88.8015.7% of flowCommon StockSEC:0001415889-25-007400:0
11,000 shares0Common StockSEC:0001415889-25-006607:0
4,373 sharesClass A Common ShareSEC:0001415889-24-016000:0
5,194 shares@ US$90.6915.4% of flowCommon StockSEC:0001415889-24-007551:0
12,500 shares0Common StockSEC:0001415889-24-007032:0
5,000 sharesClass A Common ShareSEC:0001415889-23-010563:0
3,216 shares@ US$45.724.9% of flowCommon StockSEC:0001415889-23-004558:0
12,500 shares0Common StockSEC:0001415889-23-004258:0
1,667 shares@ US$60.284.6% of flowCommon StockSEC:0001415889-22-002736:0
12,500 shares0Common StockSEC:0001415889-22-002437:0
5,000 shares@ US$28.366.4% of flowCommon StockSEC:0001179110-21-010721:0
5,000 shares@ US$28.366.3% of flowCommon StockSEC:0001179110-21-009894:0
25,000 shares@ US$28.3630.9% of flowCommon StockSEC:0001179110-21-008943:0
15 of 15 declarations
About McCain Tracey L
McCain Tracey L is Directeur Juridique. She has been a declarant across 15 filings in total, and, in the recent sampled filings, sales total 1100664 EUR between 2021-09-27 and 2025-07-21, with Levée d'options as the most frequent transaction type. She is linked to Blueprint Medicines Corp, Kiniksa Pharmaceuticals, Ltd., and Kiniksa Pharmaceuticals International, plc.
